Multicenter Postimplementation Assessment of the Positive Predictive Value of SARS-CoV-2 Antigen-Based Point-of-Care Tests Used for Screening of Asymptomatic Continuing Care Staff-Reference-Cited by-同舟云学术

Multicenter Postimplementation Assessment of the Positive Predictive Value of SARS-CoV-2 Antigen-Based Point-of-Care Tests Used for Screening of Asymptomatic Continuing Care Staff

Published:2021-10-19 Issue:11 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Kanji Jamil N.¹²³⁴^ORCID,Proctor Dustin T.⁴⁵,Stokes William²³⁶^ORCID,Berenger Byron M.²⁴^ORCID,Silvius James⁷,Tipples Graham²⁸⁹,Joffe A. Mark⁶¹⁰,Venner Allison A.⁴⁵

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, University of Calgary School of Medicine, Calgary Alberta, Canada

2. Public Health Laboratory, Alberta Precision Laboratories, Alberta, Canada

3. Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada

4. Department of Pathology and Laboratory Medicine, University of Calgary School of Medicine, Calgary, Alberta, Canada

5. Clinical Biochemistry, Alberta Precision Laboratories, Diagnostic and Scientific Center, Calgary, Alberta, Canada

6. Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

7. Division of Geriatric Medicine, Cumming School of Medicine, Calgary, Alberta, Canada

8. Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada

9. Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada

10. Alberta Health Services, Edmonton, Alberta, Canada

Abstract

Frequent screening of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among asymptomatic populations using antigen-based point-of-care tests (APOCTs) is occurring globally with limited clinical performance data. The positive predictive value (PPV) of two APOCTs used in the asymptomatic screening of SARS-CoV-2 among health care workers (HCWs) at continuing care (CC) sites across AB, Canada, was evaluated. Between 22 February and 2 May 2021, CC sites implemented SARS-CoV-2 voluntary screening of their asymptomatic HCWs. On-site testing with Abbott Panbio or BD Veritor occurred on a weekly or twice-weekly basis.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01411-21

Reference30 articles.

1. Health Canada. 2021. Priority strategies to optimize testing and screening for COVID-19 in Canada: report. Health Canada Ottawa Ontario Canada. https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/testing-screening-advisory-panel/reports-summaries/priority-strategies.html. Accessed 17 May 2021.

2. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection

3. Put to the test: use of rapid testing technologies for covid-19

4. Rapid antigen tests for SARS-CoV-2

5. Centers for Disease Control and Prevention. 19 March 2021. COVID-19 pandemic planning scenarios. Centers for Disease Control and Prevention Atlanta GA. https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html. Accessed 17 May 2021.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model for Interpreting Discordant SARS-CoV-2 Diagnostic Test Results;Emerging Infectious Diseases;2024-02

2. A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study;PLOS ONE;2023-04-06

3. Interpreting discordant SARS-CoV-2 diagnostic test results;2023-02-10

4. Modelling the impact of repeat asymptomatic testing policies for staff on SARS-CoV-2 transmission potential;Journal of Theoretical Biology;2023-01

5. Evaluation of Rapid Lateral-Flow Tests Directed against the SARS-CoV-2 Nucleoprotein Using Viral Suspensions Belonging to Different Lineages of SARS-CoV-2;Viruses;2022-11-25